NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics\u2122, Inc.to Participate in an H.C. Wainwright @ Home Fireside Di

  • WILMINGTON, Del. , April 21, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), an interventional psychiatry network wholly owned by NRx Pharmaceuticals, today announced that it will participate in an H.C.